Follow
Brenton Mar
Brenton Mar
Blueprint Medicines
Verified email at blueprintmedicines.com
Title
Cited by
Cited by
Year
Age-related clonal hematopoiesis associated with adverse outcomes
S Jaiswal, P Fontanillas, J Flannick, A Manning, PV Grauman, BG Mar, ...
New England Journal of Medicine 371 (26), 2488-2498, 2014
42812014
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
RC Lindsley, BG Mar, E Mazzola, PV Grauman, S Shareef, SL Allen, ...
Blood, The Journal of the American Society of Hematology 125 (9), 1367-1376, 2015
9632015
Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation
RC Lindsley, W Saber, BG Mar, R Redd, T Wang, MD Haagenson, ...
New England Journal of Medicine 376 (6), 536-547, 2017
7012017
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation
R Bejar, KE Stevenson, B Caughey, RC Lindsley, BG Mar, P Stojanov, ...
Journal of clinical oncology 32 (25), 2691, 2014
4512014
Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma
CJ Gibson, RC Lindsley, V Tchekmedyian, BG Mar, J Shi, S Jaiswal, ...
Journal of Clinical Oncology 35 (14), 1598, 2017
3952017
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia
S Buonamici, T Trimarchi, MG Ruocco, L Reavie, S Cathelin, BG Mar, ...
Nature 459 (7249), 1000-1004, 2009
2922009
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia
BG Mar, LB Bullinger, KM McLean, PV Grauman, MH Harris, K Stevenson, ...
Nature communications 5 (1), 3469, 2014
2052014
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
JD Kahn, PG Miller, AJ Silver, RS Sellar, S Bhatt, C Gibson, M McConkey, ...
Blood, The Journal of the American Society of Hematology 132 (11), 1095-1105, 2018
1832018
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia
BG Mar, SH Chu, JD Kahn, AV Krivtsov, R Koche, CA Castellano, ...
Blood, The Journal of the American Society of Hematology 130 (24), 2631-2641, 2017
1152017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
R Ajore, D Raiser, M McConkey, M Jöud, B Boidol, B Mar, G Saksena, ...
EMBO molecular medicine 9 (4), 498-507, 2017
1032017
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
J Gotlib, A Reiter, DH Radia, MW Deininger, TI George, J Panse, ...
Nature medicine 27 (12), 2192-2199, 2021
972021
A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31
Z Hu, I Gomes, SK Horrigan, J Kravarusic, B Mar, Z Arbieva, B Chyna, ...
Oncogene 20 (47), 6946-6954, 2001
952001
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
DJ DeAngelo, DH Radia, TI George, WA Robinson, AT Quiery, ...
Nature medicine 27 (12), 2183-2191, 2021
942021
Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia
BG Mar, L Bullinger, E Basu, K Schlis, LB Silverman, K Döhner, ...
Leukemia 26 (8), 1881-1883, 2012
852012
The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia
H Li, BG Mar, H Zhang, RV Puram, F Vazquez, BA Weir, WC Hahn, ...
Blood, the Journal of the American Society of Hematology 129 (4), 497-508, 2017
732017
The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis
BG Mar, D Amakye, I Aifantis, S Buonamici
Leukemia 25 (11), 1665-1673, 2011
712011
The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice
FC Kuo, BG Mar, RC Lindsley, NI Lindeman
Blood, The Journal of the American Society of Hematology 130 (4), 433-439, 2017
652017
Self-renewal related signaling in myeloid leukemia stem cells
FH Heidel, BG Mar, SA Armstrong
International journal of hematology 94, 109-117, 2011
562011
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia
PD Bhola, BG Mar, RC Lindsley, JA Ryan, LJ Hogdal, TT Vo, ...
The Journal of clinical investigation 126 (10), 3827-3836, 2016
442016
Novel transcription factors in human CD34 antigen–positive hematopoietic cells
I Gomes, TT Sharma, S Edassery, N Fulton, BG Mar, CA Westbrook
Blood, The Journal of the American Society of Hematology 100 (1), 107-119, 2002
372002
The system can't perform the operation now. Try again later.
Articles 1–20